Insulin lispro: experience in a private practice setting
ObjectiveTo assess the benefits (or otherwise) of changing patients with unstable type 1 diabetes to insulin lispro (Humalog, Aza Research). Participants and setting150 patients with type 1 diabetes treated in a private metropolitan physician practice. Main outcome measuresGlycohaemoglobin (%HbA1c)...
Gespeichert in:
Veröffentlicht in: | Medical journal of Australia 1999-04, Vol.170 (8), p.364-367 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | ObjectiveTo assess the benefits (or otherwise) of changing patients with unstable type 1 diabetes to insulin lispro (Humalog, Aza Research).
Participants and setting150 patients with type 1 diabetes treated in a private metropolitan physician practice.
Main outcome measuresGlycohaemoglobin (%HbA1c) value; frequency of hypoglycaemia; patients' perceptions of the two regimens.
Results125 of 150 patients completed the study; 12 (8%) withdrew because they were dissatisfied with lispro. Including these 12 patients, 80/137 patients (58%) felt better physically and 98 (72%) were more satisfied with treatment with lispro. Of the 125 patients who completed the study, 65 (52%) achieved lower HbA1c values, with 22 (18%) experiencing a fall of 1% or more; 78 patients (62%) noted less daytime hypoglycaemia and 103 (82%) experienced less nocturnal hypoglycaemia. Thirty‐ nine patients (31 %) with less daytime hypoglycaemia and 52 (42%) with less nocturnal hypoglycaemia also experienced a fall of more than 0.2% in HbA1c value (mean, 1.0%; range, 0.3%‐3.2%). There was no change in body weight or in hypoglycaemia unawareness.
ConclusionMany patients with unstable type 1 diabetes, when changed to insulin lispro, experience significant clinical and biochemical benefits. |
---|---|
ISSN: | 0025-729X 1326-5377 |
DOI: | 10.5694/j.1326-5377.1999.tb139167.x |